References
- Owczarczyk-Saczonek A., Placek W.: Compounds of psoriasis with obesity and overweight. Postępy Hig. Med. Dośw., 2017; 71: 761-772
- Zięciak T., Rzepa T., Król J., Żaba R.: Stigmatization feelings and depression symptoms in psoriasis patients. Psychiatr. Pol., 2017; 51: 1153-1163
- Auker L., Cordingley L., Pye S.R., Griffiths C.E., Young H.S.: What are the barriers to physical activity in patients with chronic plaque psoriasis? Br. J. Dermatol., 2020; 183: 1094-1102
- Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Cata-pano A.L., Cooney M.T., Corrà U., Cosyns B., Deaton C., et al.: 2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). G. Ital. Cardiol., 2017; 18: 547-612
- Do Y.K., Lakhani N., Malhotra R., Halstater B., Theng C., Østbye T.: Association between psoriasis and leisure-time physical activity: Findings from the National Health and Nutrition Examination Survey. J. Dermatol., 2015; 42: 148-153
- Ramsay B., O’Reagan M.: A survey of the social and psychological effects of psoriasis. Br. J. Dermatol., 1988; 118: 195-201
- Naldi L., Conti A., Cazzaniga S., Patrizi A., Pazzaglia M., Lanzoni A., Veneziano L., Pellacani G., Psoriasis Emilia Romagna Study Group: Diet and physical exercise in psoriasis: A randomized controlled trial. Br. J. Dermatol., 2014; 170: 634-642
- Rall L.C., Roubenoff R.: Rheumatoid cachexia: Metabolic abnormalities, mechanisms and interventions. Rheumatology, 2004; 43: 1219-1223
- Roubenoff R., Roubenoff R.A., Cannon J.G., Kehayias J.J., Zhuang H., Dawson-Hughes B., Dinarello C.A., Rosenberg I.H.: Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J. Clin. Invest., 1994; 93: 2379-2386
- Walsmith J., Roubenoff R.: Cachexia in rheumatoid arthritis. Int. J. Cardiol., 2002; 85: 89-99
- Wijnands M., Burgers A.: Stress fracture in long term methotrexate treatment for psoriatic arthritis. Ann. Rheum. Dis., 2001; 60: 736-739
- Zonneveld I.M., Bakker W.K., Dijkstra P.F., Bos J.D., van Soesbergen R.M., Dinant H.J.: Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis. Arch. Dermatol., 1996; 132: 184-187
- Simon D., Kleyer A., Bayat S., Tascilar K., Kampylafka E., Meinderink T., Schuster L., Petrov R., Liphardt A.M., Rech J., et al.: Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients. Arthritis Res. Ther., 2019; 21: 162
- Aguiar R., Sequeira J., Meirinhos T., Ambrósio C., Barcelos A.: SARCOSPA-sarcopenia in spondyloarthritis patients. Acta Reumatol. Port., 2014; 39: 322-326
- Krajewska-Włodarczyk M., Owczarczyk-Saczonek A., Placek W.: Changes in body composition and bone mineral density in post-menopausal women with psoriatic arthritis. Reumatologia, 2017; 55: 215-221
- Frediani B., Allegri A., Falsetti P., Storri L., Bisogno S., Baldi F., Filipponi P., Marcolongo R.: Bone mineral density in patients with psoriatic arthritis. J. Rheumatol., 2001; 28: 138-143
- Borman P., Babaoğlu S., Gur G., Bingol S., Bodur H.: Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin. Rheumatol., 2008; 27: 443-447
- Ogdie A., Harter L., Shin D., Baker J., Takeshita J., Choi H.K., Love T.J., Gelfand J.M.: The risk of fracture among patients with psoriatic arthritis and psoriasis: A population-based study. Ann. Rheum. Dis., 2017; 76: 882-885
- Dheda K., Cassim B., Patel N., Mody G.M.: A comparison of bone mineral density in Indians with psoriatic polyarthritis and healthy Indian volunteers. Clin. Rheumatol., 2004; 23: 89
- Häkkinen A., Sokka T., Kotaniemi A., Kautiainen H., Jappinen I., Laitinen L., Hannonen P.: Dynamic strength training in patients with early rheumatoid arthritis increases muscle strength but not bone mineral density. J. Rheumatol., 1999; 26: 1257-1263
- Komatireddy G.R., Leitch R.W., Cella K., Browning G., Minor M.: Efficacy of low load resistive muscle training in patients with rheumatoid arthritis functional class II and III. J. Rheumatol., 1997; 24: 1531-1539
- Farkas A., Kemény L.: Alcohol, liver, systemic inflammation and skin: A focus on patients with psoriasis. Skin Pharmacol. Physiol., 2013; 26: 119-126
- Kazakevich N., Moody M.N., Landau J.M., Goldberg L.H.: Alcohol and skin disorders: With a focus on psoriasis. Skin Therapy Lett., 2011; 16: 5-6
- Al-Jefri K., Newbury-Birch D., Muirhead C.R., Gilvarry E., Araújo-Soares V., Reynolds N.J., Kaner E., Hampton P.J.: High prevalence of alcohol use disorders in patients with inflammatory skin diseases. Br. J. Dermatol., 2017; 177: 837-844
- Kirby B., Richards H.L., Mason D.L., Fortune D.G., Main C.J., Griffiths C.E.: Alcohol consumption and psychological distress in patients with psoriasis. Br. J. Dermatol., 2008; 158: 138-140
- McAleer M.A., Mason D.L., Cunningham S., O’Shea S.J., McCormick P.A., Stone C., Collins P., Rogers S., Kirby B.: Alcohol misuse in patients with psoriasis: Identification and relationship to disease severity and psychological distress. Br. J. Dermatol., 2011; 164: 1256-1261
- Farkas Á., Kemény L.: Psoriasis and alcohol: Is cutaneous ethanol one of the missing links? Br. J. Dermatol., 2010; 162: 711-716
- Adamzik K., McAleer M.A., Kirby B.: Alcohol and psoriasis: Sobering thoughts. Clin. Exp. Dermatol., 2013; 38: 819-822
- Harvima I.T., Nilsson G., Suttle M.M., Naukkarinen A.: Is there a role for mast cells in psoriasis? Arch. Dermatol. Res., 2008; 300: 461-478
- Mendes L.O., Amorim J.P.A., Teixeira G.R., Chuffa L.G., Fioruci B.A., Pimentel T.A., de Mello W. Jr, Padovani C.R., Pereira S., Martinez M., et al.: Mast cells and ethanol consumption: Interactions in the prostate, epididymis and testis of UChB rats. Am. J. Reprod. Immunol., 2011; 66: 170-178
- Svanström C., Lonne-Rahm S.B., Nordlind K.: Psoriasis and alcohol. Psoriasis Targets Ther., 2019; 9: 75-79
- Gupta A.K., Pandey S.S., Pandey B.L.: Effectiveness of conventional drug therapy of plaque psoriasis in the context of consensus guidelines: A prospective observational study in 150 patients. Ann. Dermatol., 2013; 25: 156-162
- Poikolainen K., Reunala T., Karvonen J., Lauharanta J., Kärkkäinen P.: Alcohol intake: A risk factor for psoriasis in young and middle-aged men?. Br. Med. J., 1990; 300: 780-783
- Qureshi A.A., Dominguez P.L., Choi H.K., Han J., Curhan G.: Alcohol intake and risk of incident psoriasis in US women: A prospective study. Arch. Dermatol., 2010; 146: 1364-1369
- Cassano N., Vestita M., Apruzzi D., Vena G.A.: Alcohol, psoriasis, liver disease, and anti-psoriasis drugs. Int. J. Dermatol., 2011; 50: 1323-1331
- Higgins E.: The skin and alcohol. In: Comprehensive Handbook of Alcohol Related Pathology, eds.: V.R. Preedy, R.R. Watson. Elsevier Academic Press, Cambridge (MA) 2004, 599-605
- Higgins E.M., du Vivier A.W.: Cutaneous disease and alcohol misuse. Br. Med. Bull., 1994; 50: 85-98
- Parisi R., Webb R.T., Carr M.J., Moriarty K.J., Kleyn C.E., Griffiths C.E., Ashcroft D.M.: Alcohol-related mortality in patients with psoriasis a population-based cohort study. JAMA Dermatol., 2017; 153: 1256-1262
- Wu S., Cho E., Li W.Q., Han J., Qureshi A.A.: Alcohol intake and risk of incident psoriatic arthritis in women. J. Rheumatol., 2015; 42: 835-840
- Thorslund K., Svensson T., Nordlind K., Ekbom A., Fored C.M.: Use of serotonin reuptake inhibitors in patients with psoriasis is associated with a decreased need for systemic psoriasis treatment: A population-based cohort study. J. Intern. Med., 2013; 274: 281287
- Rodgman A., Perfetti T.A.: The Chemical Components of Tobacco and Tobacco Smoke. Second Edition. CRC Press, Boca Raton 2013
- Morris P.B., Ference B.A., Jahangir E., Feldman D.N., Ryan J.J., Bahrami H., El-Chami M.F., Bhakta S., Winchester D.E., Al-Mallah M.H., et al.: Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: Clinical perspectives from the prevention of cardiovascular disease section leadership council and early career councils of the American College of Cardiology. J. Am. Coll. Cardiol., 2015; 66: 1378-1391
- Sopori M.: Effects of cigarette smoke on the immune system. Nat. Rev. Immunol., 2002; 2: 372-377
- Armstrong A.W., Armstrong E.J., Fuller E.N., Sockolov M.E., Voyles S.V.: Smoking and pathogenesis of psoriasis: A review of oxidative, inflammatory and genetic mechanisms. Br. J. Dermatol., 2011; 165: 1162-1168
- Yanagita M., Kobayashi R., Kojima Y., Mori K., Murakami S.: Nicotine modulates the immunological function of dendritic cells through peroxisome proliferator-activated receptor-γ upregulation. Cell. Immunol., 2012; 274: 26-33
- Baba N., Rubio M., Kenins L., Regairaz C., Woisetschlager M., Carballido J.M., Sarfati M.: The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naïve CD4+ Th cells to promote the development of IL-22-secreting Th cells. Hum. Immunol., 2012; 73: 795-800
- Jin Y., Yang S., Zhang F., Kong Y., Xiao F., Hou Y., Fan X., Zhang X.: Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: A hospital-based case-control study in China. J. Eur. Acad. Dermatol. Venereol., 2009; 23: 132-137
- Sałata-Nowak J., Flisiak I., Chodynicka B.: Wpływ dymu tytoniowego na skórȩ. Przegl. Dermatol., 2010; 97: 342-348
- Mills C.M., Srivastava E.D., Harvey I.M., Swift G.L., Newcombe R.G., Holt P.J., Rhodes J.: Smoking habits in psoriasis: A case control study. Br. J. Dermatol., 1992; 127: 18-21
- Naldi L., Tognoni G., Cainelli T.: Analytic epidemiology in psoriasis. J. Invest. Dermatol., 1994; 102: 19S-23S
- Lee Y.H., Song G.G.: Association between circulating 25-hydroxyvitamin D levels and psoriasis, and correlation with disease severity: A meta-analysis. Clin. Exp. Dermatol., 2018; 43: 529-535
- Armstrong A.W., Harskamp C.T., Dhillon J.S., Armstrong E.J.: Psoriasis and smoking: A systematic review and meta-analysis. Br. J. Dermatol., 2014; 170: 304-314
- Herron M.D., Hinckley M., Hoffman M.S., Papenfuss J., Hansen C.B., Callis K.P., Krueger G.G.: Impact of obesity and smoking on psoriasis presentation and management. Arch. Dermatol., 2005; 141: 1527-1534
- Gisondi P., Tessari G., Conti A., Piaserico S., Schianchi S., Peserico A., Giannetti A., Girolomoni G.: Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study. Br. J. Dermatol., 2007; 157: 68-73
- Altunay I., Doner N., Mercan S., Demirci G.T.: Stress coping mechanisms in smoking psoriatics. Dermatol. Sin., 2013; 31: 130133
- Fortes C., Mastroeni S., Leffondré K., Sampogna F., Melchi F., Mazzotti E., Pasquini P., Abeni D.: Relationship between smoking and the clinical severity of psoriasis. Arch. Dermatol., 2005; 141: 1580-1584
- Naldi L.: Psoriasis and smoking: Links and risks. Psoriasis, 2016; 6: 65-71
- Eriksson M.O., Hagforsen E., Lundin I.P., Michaëlsson G.: Palmoplantar pustulosis: A clinical and immunohistological study. Br. J. Dermatol., 1998; 138: 390-398
- Michaëlsson G., Gustafsson K., Hagforsen E.: The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking. J. Am. Acad. Dermatol., 2006; 54: 737-738
- Setty A.R., Curhan G., Choi H.K.: Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am. J. Med., 2007; 120: 953-959
- Li W., Han J., Qureshi A.A.: Smoking and risk of incident psoriatic arthritis in US women. Ann. Rheum. Dis., 2012; 71: 804-808
- Nguyen U.D., Zhang Y., Lu N., Louie-Gao Q., Niu J., Ogdie A., Gelfand J.M., LaValley M.P., Dubreuil M., Sparks J.A., et al.: Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: A population-based study. Ann. Rheum. Dis., 2018; 77: 119-123
- Tillett W., Jadon D., Shaddick G., Cavill C., Korendowych E., de Vries C.S., McHugh N.: Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann. Rheum. Dis., 2013; 72: 1358-1361
- Thorneloe R.J., Bundy C., Griffiths C.E.M., Ashcroft D.M., Cordingley L.: Adherence to medication in patients with psoriasis: A systematic literature review. Br. J. Dermatol., 2013; 168: 20-31
- Kinahan C.E., Mazloom S., Fernandez A.P.: Impact of smoking on response to systemic treatment in patients with psoriasis: A retrospective case-control study. Br. J. Dermatol., 2015; 172: 428436
- Di Lernia V., Ricci C., Lallas A., Ficarelli E.: Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: A retrospective study. J. Dermatolog. Treat., 2014; 25: 73-74
- Højgaard P., Glintborg B., Hetland M.L., Hansen T.H., Lage-Hansen P.R., Petersen M.H., Holland-Fischer M., Nilsson C., Loft A.G., Andersen B.N., et al.: Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: Results from the DANBIO registry. Ann. Rheum. Dis., 2015; 74: 2130-2136
- Owczarczyk-Saczonek A.B., Owczarczyk J., Krajewska-Włodarczyk M., Wojtkiewicz J., Placek W.. Are psoriasis and psoriatic arthritis associated with chronic obstructive pulmonary disease? Przegl. Dermatol., 2019; 106: 185-197
- Hrehorów E., Salomon J., Matusiak L., Reich A., Szepietowski J.C.: Patients with psoriasis feel stigmatized. Acta Derm. Venereol., 2012; 92: 67-72
- Shelton R.C., Miller A.H.: Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression. Prog. Neurobiol., 2010; 91: 275-299
- Ogłodek E., Marek L., Araszkiewicz A., Placek W., Moś D.: Aleksytymia u pacjenta choruja̧ cego na łuszczycȩ i depresjȩ. Przegl. Dermatol., 2009; 96: 363-366
- Chen Y., Xin T., Cheng A.S.: Evaluating the effectiveness of psychological and/or educational interventions in psoriasis: A narrative review. J. Dermatol., 2014; 41: 775-778
- Kurd S.K., Troxel A.B., Crits-Christoph P., Gelfand J.M.: The risk of depression, anxiety, and suicidality in patients with psoriasis: A population-based cohort study. Arch. Dermatol., 2010; 146: 891895
- Wojtyna E., Łakuta P., Marcinkiewicz K., Bergler-Czop B., Brzezińska-Wcisło L.: Gender, body image and social support: Biopsychosocial determinants of depression among patients with psoriasis. Acta Derm. Venereol., 2017; 97: 91-97
- Singh S., Taylor C., Kornmehl H., Armstrong A.W.: Psoriasis and suicidality: A systematic review and meta-analysis. J. Am. Acad. Dermatol., 2017; 77: 425-440.2
- Takahashi H., Tsuji H., Honma M., Shibaki H., Nakamura S., Hashimoto Y., Takahashi M., Koike K., Takei A., Ishida-Yamamoto A., Iizuka H.: Japanese patients with psoriasis and atopic dermatitis show distinct personality profiles. J. Dermatol., 2013; 40: 370373
- Randa H., Lomholt J.J., Skov L., Zachariae R.: Health-related quality of life in adolescents with psoriasis: An interview-based study. Br. J. Dermatol., 2018; 178: 1404-1411
- Łakuta P., Przybyła-Basista H.: Toward a better understanding of social anxiety and depression in psoriasis patients: The role of determinants, mediators, and moderators. J. Psychosom. Res., 2017; 94: 32-38
- Lim D.S., Bewley A., Oon H.H.: Psychological profile of patients with psoriasis. Ann. Acad. Med. Singap., 2018; 47: 516-522
- Krajewska-Włodarczyk M., Owczarczyk-Saczonek A., Placek W.: Sleep disorders in patients with psoriatic arthritis and psoriasis. Reumatologia, 2018; 56: 301-306
- Gupta M.A., Simpson F.C., Gupta A.K.: Psoriasis and sleep disorders: A systematic review. Sleep Med. Rev., 2016; 29: 63-75
- Fortune D.G., Richards H.L., Kirby B., Bowcock S., Main C.J., Griffiths C.E.: A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br. J. Dermatol., 2002; 146: 458-465
- Piaserico S., Marinello E., Dessi A., Linder M.D., Coccarielli D., Peserico A.: Efficacy of biofeedback and cognitive-behavioural therapy in psoriatic patients: A single-blind, randomized and controlled study with added narrow-band ultraviolet B therapy. Acta Derm. Venereol., 2016; 96: 91-95
- Tausk F., Whitmore S.E.: A pilot study of hypnosis in the treatment of patients with psoriasis. Psychother. Psychosom., 1999; 68: 221-225
- Gaston L., Crombez J.C., Joly J., Hodgins S., Dumont M.: Efficacy of imagery and meditation techniques in treating psoriasis. Imagin. Cogn. Pers., 1989; 8: 25-38
- Kabat-Zinn J., Wheeler E., Light T., Skillings A., Scharf M.J., Cropley T.G., Hosmer D., Bernhard J.D.: Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom. Med., 1998; 60: 625-632
- Lazaroff I., Shimshoni R.: Effects of medical resonance therapy music on patients with psoriasis and neurodermatitis - a pilot study. Integr. Physiol. Behav. Sci., 2000; 35: 189-198
- Lavda A.C., Webb T.L., Thompson A.R.: A meta-analysis of the effectiveness of psychological interventions for adults with skin conditions. Br. J. Dermatol., 2012; 167: 970-979
- Moon H.S., Mizara A., McBride S.R.: Psoriasis and psycho-dermatology. Dermatol. Ther., 2013; 3: 117-130
- Riyaz N., Arakkal F.R.: Spa therapy in dermatology. Indian J. Dermatol. Venereol. Leprol., 2011; 77: 128-134
- Harari M.: Climatoterapia de las enfermedades de la Piel en el Mar Muerto - una Actualización. An. Hidrol. Médica., 2012; 5: 3951
- Kazandjieva J., Grozdev I., Darlenski R., Tsankov N.: Climatotherapy of psoriasis. Clin. Dermatol., 2008; 26: 477-485
- Hodak E., Gottlieb A.B., Segal T., Politi Y., Maron L., Sulkes J., David M.: Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: Combined effects on epidermal and immunologic activation. J. Am. Acad. Dermatol., 2003; 49: 451-457
- Péter I., Jagicza A., Ajtay Z., Boncz I., Kiss I., Szendi K., Kustán P., Németh B.: Balneotherapy in psoriasis rehabilitation. In Vivo, 2017; 31: 1163-1168
- Abels D.J., Rose T., Bearman J.E.: Treatment of psoriasis at a Dead Sea dermatology clinic. Int. J. Dermatol., 1995; 34: 134-137
- Emmanuel T., Lybæk D., Johansen C., Iversen L.: Effect of Dead Sea climatotherapy on psoriasis; A prospective cohort study. Front. Med., 2020; 7: 83
- Shani J., Harari M., Hristakieva E., Seidl V., Bar-Giyora J.: Dead-Sea climatotherapy versus other modalities of treatment for psoriasis: Comparative cost-effectiveness. Int. J. Dermatol., 1999; 38: 252-262
- Golušin Z., Jovanović M., Gajinov B.J., Jolić S.: Balneotherapy of psoriasis. Serbian J. Dermatol. Venereol., 2015; 6: 105-112
- Soroka Y., Ma’or Z., Leshem Y., Verochovsky L., Neuman R., Brégégère F.M., Milner Y.: Aged keratinocyte phenotyping: Morphology, biochemical markers and effects of Dead Sea minerals. Exp. Gerontol., 2008; 43: 947-957
- Dawe R.S., Yule S., Cameron H., Moseley H., Ibbotson S.H., Ferguson J.: A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. Br. J. Dermatol., 2005; 153: 613-619
- Boros M., Kemény Á., Sebők B., Bagoly T., Perkecz A., Petőházi Z., Maász G., Schmidt J., Márk L., László T., et al.: Sulphurous medicinal waters increase somatostatin release: It is a possible mechanism of anti-inflammatory effect of balneotherapy in psoriasis. Eur. J. Integr. Med., 2013; 5: 109-118
- Gálvez Galve J.J., Peiró P.S., Lucas M.O., Torres A.H., Gil E.S., Pérez M.B.: Quality of life and assessment after local application of sulphurous water in the home environment in patients with psoriasis vulgaris: A randomised placebo-controlled pilot study. Eur. J. Integr. Med., 2012; 4: e213-e218
- Khalilzadeh S., Shirbeigi L., Naghizadeh A., Mehriardestani M., Shamohammadi S., Tabarrai M.: Use of mineral waters in the treatment of psoriasis: Perspectives of Persian and conventional medicine. Dermatol. Ther., 2019; 32: e12969
- Damevska K., França K., Lotti T., Nikolovska S., Pollozhani N.: Complementary and integrative therapies for psoriasis: Looking forward. Dermatol. Ther., 2018; 31: e12627
- Melandri D., Albano V.M., Venturi M., Flamigni A., Vairetti M.: Efficacy of combined liman peloid baths and heliotherapy in the treatment of psoriasis at Cervia spa, Emilia, Italy. Int. J. Biometeorol., 2020; 64: 1145-1152
- Rokowska-Waluch A., Pielesiak A., Pawlaczyk M.: Spa-terapia w leczeniu łuszczycy. Przegl. Dermatol., 2009; 96: 367-370
- Tsankov N.K.: High mountain climatotherapy. Clin. Dermatol., 1998; 16: 699-707